The expression level of EZH2 was negatively correlated with SPRY4-IT1 expression levels in NSCLC tissues (Figure 2c), and increased EZH2 expression in NSCLC tissues significantly correlated with tumor size, advanced pathological stage, and lymph node metastasis (Supplementary Table 5). This evidence concerns the gene EZH2 and non-small cell lung carcinoma.